Lindstrøm JC, Gjerdrum HSV, Brynildsrud OB, Tannæs TM, Kristoffersen AB, Ricanek P, Leegaard TM, Bjørnholt JV, Jørgensen SB, Tunsjø HS, Olbjørn C, Detlie TE, Jahnsen J, Kristensen VA, Høivik ML, Hov JR, Moen AE, IBSEN-III Study group (2026)
Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patients
BMC Microbiol (in press)
DOI 10.1186/s12866-026-05101-9, PubMed 42045813

Hansen SH, Bhattacharjee N, Hu C, Maseng MG, Grannö O, Bang C, Olbjørn C, Perminow G, Valeur J, Bengtson MB, Frigstad SO, Andersen S, Aabrekk TB, Detlie TE, Franke A, Kristensen VA, Halfvarson J, Høivik ML, Iyer RK, Hov J (2026)
Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categories
Microbiome Res Rep, 5 (1), 4
DOI 10.20517/mrr.2025.96, PubMed 42016722

Maseng MG, Hansen SH, Grännö O, Bang C, Lund C, Huppertz-Hauss G, Perminow G, Valeur J, Bengtson MB, Opheim R, Boyar R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VA, Strande V, Hovde Ø, Asak Ø, Franke A, Halfvarsson J, Høivik ML, Hov JR (2026)
Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study
Inflamm Bowel Dis (in press)
DOI 10.1093/ibd/izag051, PubMed 41966990